Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,137 | 47,521 | 161,669 | 53,428 | 60,081 |
| Marketable Securities | 231,428 | 250,869 | 157,461 | 147,771 | 215,765 |
| Receivables | 18,512 | 19,306 | 17,598 | 14,695 | 14,867 |
| Inventories | 18,741 | 13,895 | 11,994 | 8,507 | 8,624 |
| TOTAL | $374,200 | $340,341 | $357,366 | $235,753 | $308,268 |
| Non-Current Assets | |||||
| PPE Net | 632 | 801 | 973 | 1,149 | 1,341 |
| Intangibles | 6,174 | 6,388 | 6,601 | 6,815 | 7,028 |
| Other Non-Current Assets | 11,267 | 16,042 | 16,906 | 14,934 | 16,108 |
| TOTAL | $18,073 | $23,231 | $24,480 | $22,898 | $24,477 |
| Total Assets | $392,273 | $363,572 | $381,846 | $258,651 | $332,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,328 | 4,887 | 4,543 | 7,550 | 4,885 |
| Accrued Expenses | 62,658 | 54,797 | 48,077 | 44,531 | 48,262 |
| Other current liabilities | 37,704 | 36,635 | N/A | N/A | N/A |
| TOTAL | $115,517 | $97,605 | $54,722 | $54,160 | $55,203 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,827 | 1,286 | 1,286 | 1,286 | 1,286 |
| Other Non-Current Liabilities | 3,938 | 4,030 | 39,257 | 35,542 | 1,640 |
| TOTAL | $112,207 | $113,271 | $147,629 | $142,910 | $107,783 |
| Total Liabilities | $227,724 | $210,876 | $202,351 | $197,070 | $162,986 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,224 | 61,457 | 61,134 | 60,973 | 60,141 |
| Common Shares | 61 | 61 | 60 | 60 | 59 |
| Retained earnings | -1,155,338 | -1,112,010 | -1,068,369 | -1,036,108 | -894,736 |
| Other shareholders' equity | 142,781 | 140,877 | 139,535 | -181 | 134 |
| TOTAL | $164,549 | $152,696 | $179,495 | $61,581 | $169,759 |
| Total Liabilities And Equity | $392,273 | $363,572 | $381,846 | $258,651 | $332,745 |